Chronic Myeloid Leukemia Patients in Prolonged Remission following Interferon-α Monotherapy Have Distinct Cytokine and Oligoclonal Lymphocyte Profile
出版年份 2011 全文链接
标题
Chronic Myeloid Leukemia Patients in Prolonged Remission following Interferon-α Monotherapy Have Distinct Cytokine and Oligoclonal Lymphocyte Profile
作者
关键词
-
出版物
PLoS One
Volume 6, Issue 8, Pages e23022
出版商
Public Library of Science (PLoS)
发表日期
2011-08-10
DOI
10.1371/journal.pone.0023022
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Interferon alpha for Treatment of Chronic Myeloid Leukemia
- (2012) Bengt Simonsson et al. CURRENT DRUG TARGETS
- Anti-Leukemia Activity of In Vitro-Expanded Human Gamma Delta T Cells in a Xenogeneic Ph+ Leukemia Model
- (2011) Gabrielle M. Siegers et al. PLoS One
- Mono/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy
- (2010) A. Kreutzman et al. BLOOD
- Immunoprofiling of patients with chronic myeloid leukemia at diagnosis and during tyrosine kinase inhibitor therapy
- (2010) Peter Rohon et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- The response to imatinib and interferon- is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase
- (2010) F. Palandri et al. HAEMATOLOGICA
- Sustained Molecular Response With Interferon Alfa Maintenance After Induction Therapy With Imatinib Plus Interferon Alfa in Patients With Chronic Myeloid Leukemia
- (2010) Andreas Burchert et al. JOURNAL OF CLINICAL ONCOLOGY
- Pegylated IFN-α2a combined to imatinib mesylate 600mg daily can induce complete cytogenetic and molecular responses in a subset of chronic phase CML patients refractory to IFN alone or to imatinib 600mg daily alone
- (2010) Franck E. Nicolini et al. LEUKEMIA RESEARCH
- Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia
- (2010) Claude Preudhomme et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
- (2010) Hagop Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia
- (2010) Giuseppe Saglio et al. NEW ENGLAND JOURNAL OF MEDICINE
- PR1-Specific T Cells Are Associated with Unmaintained Cytogenetic Remission of Chronic Myelogenous Leukemia After Interferon Withdrawal
- (2010) Shreya Kanodia et al. PLoS One
- Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia
- (2009) A Hochhaus et al. LEUKEMIA
- Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy
- (2009) S Mustjoki et al. LEUKEMIA
- CD8+ memory T cells predominate over naïve T cells in therapy-free CML patients with sustained major molecular response
- (2009) Kensuke Usuki et al. LEUKEMIA RESEARCH
- IFNα activates dormant haematopoietic stem cells in vivo
- (2009) Marieke A. G. Essers et al. NATURE
- Natural killer and γδ T cells in haematological malignancies: enhancing the immune effectors
- (2009) Jérôme Rey et al. TRENDS IN MOLECULAR MEDICINE
- Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomib
- (2008) A. S. M. Yong et al. BLOOD
- Does chemotherapy modify the immune surveillance of hematological malignancies?
- (2008) A J Barrett et al. LEUKEMIA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search